2017
Elevated plasma concentrations of S100 calcium-binding protein B and tumor necrosis factor alpha in children with autism spectrum disorders
Guloksuz SA, Abali O, Cetin E, Gazioglu S, Deniz G, Yildirim A, Kawikova I, Guloksuz S, Leckman JF. Elevated plasma concentrations of S100 calcium-binding protein B and tumor necrosis factor alpha in children with autism spectrum disorders. Brazilian Journal Of Psychiatry 2017, 39: 195-200. PMID: 28099628, PMCID: PMC7111377, DOI: 10.1590/1516-4446-2015-1843.Peer-Reviewed Original ResearchConceptsTumor necrosis factor alphaNecrosis factor alphaS100B concentrationsPlasma concentrationsFactor alphaChildhood Autism Rating ScaleS100 calcium-binding protein BCalcium-binding protein BElevated plasma concentrationsTNF-α concentrationsAutism spectrum disorderIL-17AIL-10Cytokine concentrationsInflammatory cytokinesIL-6Peripheral concentrationsHealthy childrenIL-4Plasma levelsSpectrum disorderImmune functionInterferon gammaImmune systemS100B
2002
Characteristics of acute stress symptoms and nitric oxide concentration in young rescue workers in Taiwan
Yeh CB, Leckman J, Wan FJ, Shiah IS, Lu RB. Characteristics of acute stress symptoms and nitric oxide concentration in young rescue workers in Taiwan. Psychiatry Research 2002, 112: 59-68. PMID: 12379451, DOI: 10.1016/s0165-1781(02)00179-8.Peer-Reviewed Original ResearchConceptsAcute stress disorderYoung military personnelControl groupMale military personnelNitric oxideInitial evaluationMilitary personnelPoint prevalence ratesAcute stress symptomsDSM-IV criteriaSignificant inverse correlationStress symptomsNitric oxide concentrationPlasma concentrationsPlasma measuresPrevalence ratesRelated syndromesNeuropsychological interviewStress disorderInverse correlationPlasma samplesLongitudinal studyPotential roleRescue workersDisaster workers
1989
Plasma debrisoquin levels in the assessment of reduction of plasma homovanillic acid. The debrisoquin method.
Riddle MA, Jatlow PI, Anderson GM, Cho SC, Hardin MT, Cohen DJ, Leckman JF. Plasma debrisoquin levels in the assessment of reduction of plasma homovanillic acid. The debrisoquin method. Neuropsychopharmacology 1989, 2: 123-9. PMID: 2742727, DOI: 10.1016/0893-133x(89)90015-8.Peer-Reviewed Original ResearchConceptsCentral nervous systemPeripheral HVA productionDebrisoquin sulfatePHVA levelsHomovanillic acidPlasma homovanillic acidCerebrospinal fluid samplesAssessment of reductionDopamine metabolismPlasma concentrationsNervous systemFluid samplesSubstantial inhibitionHVACN metabolismDoseComplete inhibitionDopamineSubjectsInhibitionMetabolismDebrisoquinLevelsPHVA